193 related articles for article (PubMed ID: 11191113)
21. Anti-diol epoxide of benzo[a]pyrene induces transient Mdm2 and p53 Ser15 phosphorylation, while anti-diol epoxide of dibenzo[a,l]pyrene induces a nontransient p53 Ser15 phosphorylation.
Pääjärvi G; Jernström B; Seidel A; Stenius U
Mol Carcinog; 2008 Apr; 47(4):301-9. PubMed ID: 17932951
[TBL] [Abstract][Full Text] [Related]
22. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
[TBL] [Abstract][Full Text] [Related]
23. Induction of cell death, DNA strand breaks, and cell cycle arrest in DU145 human prostate carcinoma cell line by benzo[a]pyrene and benzo[a]pyrene-7,8-diol-9,10-epoxide.
Nwagbara O; Darling-Reed SF; Tucker A; Harris C; Abazinge M; Thomas RD; Gragg RD
Int J Environ Res Public Health; 2007 Mar; 4(1):10-4. PubMed ID: 17431309
[TBL] [Abstract][Full Text] [Related]
24. Alterations in human B cell calcium homeostasis by polycyclic aromatic hydrocarbons: possible associations with cytochrome P450 metabolism and increased protein tyrosine phosphorylation.
Mounho BJ; Burchiel SW
Toxicol Appl Pharmacol; 1998 Mar; 149(1):80-9. PubMed ID: 9512730
[TBL] [Abstract][Full Text] [Related]
25. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
[TBL] [Abstract][Full Text] [Related]
26. Effects of the environmental mammary carcinogen 6-nitrochrysene on p53 and p21(Cip1) protein expression and cell cycle regulation in MCF-7 and MCF-10A cells.
Sun YW; Herzog CR; Krzeminski J; Amin S; Perdew G; El-Bayoumy K
Chem Biol Interact; 2007 Oct; 170(1):31-9. PubMed ID: 17678638
[TBL] [Abstract][Full Text] [Related]
27. Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.
Galmarini CM; Clarke ML; Falette N; Puisieux A; Mackey JR; Dumontet C
Int J Cancer; 2002 Feb; 97(4):439-45. PubMed ID: 11802204
[TBL] [Abstract][Full Text] [Related]
28. Benzo[a]pyrene, but not 2,3,7,8-TCDD, induces G2/M cell cycle arrest, p21CIP1 and p53 phosphorylation in human choriocarcinoma JEG-3 cells: a distinct signaling pathway.
Drukteinis JS; Medrano T; Ablordeppey EA; Kitzman JM; Shiverick KT
Placenta; 2005 Apr; 26 Suppl A():S87-95. PubMed ID: 15837074
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin Protein Ligase Ring2 Is Involved in S-phase Checkpoint and DNA Damage in Cells Exposed to Benzo[a]pyrene.
Yang J; Chen W; Fan Y; Zhang H; Wang W; Zhang H
J Biochem Mol Toxicol; 2016 Oct; 30(10):481-488. PubMed ID: 27095601
[TBL] [Abstract][Full Text] [Related]
30. Differential c-myc expression profiles in normal human bronchial epithelial cells following treatment with benzo[a]pyrene, benzo[a]pyrene-4,5 epoxide, and benzo[a]pyrene-7,8-9,10 diol epoxide.
Fields WR; Desiderio JG; Leonard RM; Burger EE; Brown BG; Doolittle DJ
Mol Carcinog; 2004 Jun; 40(2):79-89. PubMed ID: 15170813
[TBL] [Abstract][Full Text] [Related]
31. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
32. Mutagenicity of benzo[a]pyrene bay-region sulfonates.
Green JL; Pan YH; Reed GA
Carcinogenesis; 1991 Jul; 12(7):1359-62. PubMed ID: 1906381
[TBL] [Abstract][Full Text] [Related]
33. Low-dose benzo(a)pyrene and its epoxide metabolite inhibit myogenic differentiation in human skeletal muscle-derived progenitor cells.
Chiu CY; Yen YP; Tsai KS; Yang RS; Liu SH
Toxicol Sci; 2014 Apr; 138(2):344-53. PubMed ID: 24431215
[TBL] [Abstract][Full Text] [Related]
34. Role and interaction of p53, BAX and the stress-activated protein kinases p38 and JNK in benzo(a)pyrene-diolepoxide induced apoptosis in human colon carcinoma cells.
Donauer J; Schreck I; Liebel U; Weiss C
Arch Toxicol; 2012 Feb; 86(2):329-37. PubMed ID: 21983885
[TBL] [Abstract][Full Text] [Related]
35. Impact of GSTM1 on aromatic-DNA adducts and p53 accumulation in human skin and lymphocytes.
Godschalk RW; Ostertag JU; Zandsteeg AM; Van Agen B; Neuman HA; Van Straaten H; Van Schooten FJ
Pharmacogenetics; 2001 Aug; 11(6):537-43. PubMed ID: 11505223
[TBL] [Abstract][Full Text] [Related]
36. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
37. Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein.
Gudas JM; Nguyen H; Li T; Sadzewicz L; Robey R; Wosikowski K; Cowan KH
Carcinogenesis; 1996 Jul; 17(7):1417-27. PubMed ID: 8706243
[TBL] [Abstract][Full Text] [Related]
38. Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events.
Plísková M; Vondrácek J; Vojtesek B; Kozubík A; Machala M
Toxicol Sci; 2005 Feb; 83(2):246-56. PubMed ID: 15548639
[TBL] [Abstract][Full Text] [Related]
39. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors.
Sourvinos G; Spandidos DA
Biochem Biophys Res Commun; 1998 Apr; 245(1):75-80. PubMed ID: 9535786
[TBL] [Abstract][Full Text] [Related]
40. Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells.
Tampio M; Loikkanen J; Myllynen P; Mertanen A; Vähäkangas KH
Toxicol Lett; 2008 May; 178(3):152-9. PubMed ID: 18440733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
